Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient Mice
Seiji Yano(Kanazawa University Hospital), Saburo Sone(Io Therapeutics (United States)), Hiroaki Muguruma(Tokushima University), Nobutaka Edakuni(Tokushima University), Hisanori Uehara(Tokushima University Hospital), Hisatsugu Goto(Tokushima University), Yuka Matsumori, Hideki Tomimoto(Tokushima University), Akihiko Yamamoto, Anderson J. Ryan(University of Oxford), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Emiko Nakataki(Tokushima University)
Cited by 48
Related Papers
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
|Nature Communications|2019|360
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175